“…Protein tyrosine phosphatase 1B (PTP1B), a negative regulator in the insulin signaling pathway, was evidenced as a promising drug target for type 2 diabetes. The prenylated flavonoids, macarangin ( 143 ), bonannione A ( 337 ), bonanniol A ( 378 ), (2 E )-1-(5,7-dihydroxy-2,2,6-trimethyl-2 H -benzopyran-8-yl)-3-(4-methoxyphenyl)-2-propen-1-one ( 588 ), (2 E )-1-(5,7-dihydroxy-2,2-dimethyl-2 H -benzopyran-8-yl)-3-phenyl-2-propen-1-one ( 589 ), and laxichalcone ( 656 ), from Macaranga denticulate showed potential inhibitory activities against PTP1B in vitro with an IC 50 value of 22.7, 14.0, 15.2, 48.8, 19.3, and 20.7 µ M, respectively (Zhang et al 2016 ). 166 , cudraflavone C ( 167 ), cudraflavanone D ( 472 ), and euchrestaflavanone C ( 510 ) derived from the roots of Cudrania tricuspidate , showed PTP1B inhibitory activities with IC 50 values of 13.6, 9.4, 5.7, and 12.3 µ M, respectively (Quang et al 2015 ).…”